2010
DOI: 10.1371/journal.pntd.0000845
|View full text |Cite
|
Sign up to set email alerts
|

CD8+ T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis

Abstract: BackgroundIn human leishmaniasis Th1/Th2 dichotomy similar to murine model is not clearly defined and surrogate marker(s) of protection is not yet known. In this study, Th1/Th2 cytokines (IL-5, IL-10, IL-13 and IFN-γ) profile induced by purified CD4+/CD8+ T cells in response to Leishmania antigens were assessed at transcript and protein levels in 14 volunteers with a history of self-healing cutaneous leishmaniasis (HCL) and compared with 18 healthy control volunteers.Methodology/Principal FindingsCD4+/CD8+/CD1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
68
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(68 citation statements)
references
References 47 publications
(64 reference statements)
0
68
0
Order By: Relevance
“…Immunotherapy against visceral leishmaniasis is challenging partly because of immunosuppression (31)(32)(33)(34). Myeloid cells are a major source of T cell suppression in many diseases, including leishmaniasis (13).…”
Section: Discussionmentioning
confidence: 99%
“…Immunotherapy against visceral leishmaniasis is challenging partly because of immunosuppression (31)(32)(33)(34). Myeloid cells are a major source of T cell suppression in many diseases, including leishmaniasis (13).…”
Section: Discussionmentioning
confidence: 99%
“…ϩ T cells (34). Recently, in BALB/c mice vaccinated with Toll-like receptor (TLR) ligands (DNA priming) plus TLR1 and TLR2 agonists as an adjuvant, protection against Leishmania (Viannia) panamensis was found to be dependent on the memory of CD8 ϩ T cells and on IFN-␥ production (35).…”
Section: Fig 6 Granzyme B Mediates Cd8mentioning
confidence: 99%
“…This is also the case in visceral leishmaniasis caused by L. donovani , in mice and humans where IFN-γ-producing Th1 cells protect against severe disease (Kushawaha, Gupta, Sundar, Sahasrabuddhe, & Dube, 2011). In human cutaneous leishmaniasis IFN-γ production by CD8+ T cells seems to contribute to disease resolution (Mary, Auriault, Faugère, & Dessein, 1999; Nateghi Rostami et al, 2010). However, as demonstrated by Leishmania infection models using CD4 or CD8 deficient mice, while CD4 T cells are required for resolution of disease (Chakkalath et al, 1995), the role of CD8 T cells in immunity to cutaneous or visceral leishmaniasis seems to depend on the model used (Belkaid, Von Stebut, et al, 2002; Erb, Blank, Ritter, Bluethmann, & Moll, 1996; Gomes-Pereira, Rodrigues, Rolão, Almeida, & Santos-Gomes, 2004; Huber, Timms, Mak, Röllinghoff, & Lohoff, 1998; Tsagozis, Karagouni, & Dotsika, 2005).…”
Section: Immunity To Leishmaniamentioning
confidence: 99%